Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 15 citing articles:

Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer
Mohd Rais Mustafa, Kashif Abbas, Mudassir Alam, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
TCR-T cell therapy: current development approaches, preclinical evaluation, and perspectives on regulatory challenges
Elena A. Golikova, Alina Alshevskaya, Saleh Alrhmoun, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Ultrasound-Guided Histotripsy Triggers the Release of Tumor-Associated Antigens from Breast Cancers
Shengzhuang Tang, Reliza McGinnis, Zhengyi Cao, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 183-183
Open Access
The Icarian flight of antibody-drug conjugates: target selection amidst complexity and tackling adverse impacts
Han Liu, Hongye Zeng, Xiaojing Qin, et al.
Protein & Cell (2025)
Open Access
Her-2 nanobody modified cisplatin nanoparticles for precise chemotherapy of colon cancer
Wenjun Liang, Yan Zhang, Jianpeng Li, et al.
Journal of Microencapsulation (2025), pp. 1-9
Open Access
Target-Driven Tissue-Agnostic Drug Approvals—A New Path of Drug Development
Kyaw Zin Thein, Yin Mon Myat, Byung Park, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2529-2529
Open Access | Times Cited: 3
Molecularly Imprinted Polymers-based Biosensors for Gynecological Diagnostics and Monitoring
Faezeh Ghorbanizamani, Hichem Moulahoum, Figen Zıhnıoglu, et al.
Talanta Open (2024), pp. 100364-100364
Open Access | Times Cited: 3
An Insight on Functioning Pancreatic Neuroendocrine Neoplasms
Michele Bevere, Αναστάσιος Γκουντάκος, Filippo Maria Martelli, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 303-303
Open Access | Times Cited: 8
Target-Driven Tissue-Agnostic Drug Approvals; a New Path of Drug Development
Kyaw Zin Thein, Yin Mon Myat, Byung Park, et al.
(2024)
Open Access | Times Cited: 2
Narrative review on the evolving role of HER2/neu targeting in uterine serous cancers
Aarthi S Jayraj, Salamatu Abdul-Aziz, Anisa Mburu, et al.
Annals of Translational Medicine (2024) Vol. 12, Iss. 4, pp. 69-69
Open Access | Times Cited: 2
Biomarker Panel for Early Detection in Uterine Cancer: A Review
N. Deepthi Priya, K. V. Nanda kumar, M. Siva Charani, et al.
Asian Pacific Journal of Cancer Biology (2024) Vol. 9, Iss. 2, pp. 201-208
Open Access | Times Cited: 2
Antibody-Drug Conjugates in Breast Cancer: Toward a Molecular Perspective Into Clinical Practice
Roberto Paz-Manrique, Joseph A. Pinto, Guillermo Valencia
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 1
Outcomes of Third-Line Trastuzumab Deruxtecan in a Patient with De Novo Stage 4 HER2-Positive Gastric Adenocarcinoma with Enteroblastic Differentiation: A Case Report
Roger Kai‐Cheong Ngan
Life (2023) Vol. 13, Iss. 9, pp. 1851-1851
Open Access | Times Cited: 3
Targeting Precision in Cancer Immunotherapy: Naturally-Occurring Antigen-Specific TCR Discovery with Single-Cell Sequencing
Saleh Alrhmoun, M.S. Fisher, Julia Lopatnikova, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4020-4020
Open Access
Prophylactic Vaccination and Intratumoral Boost with HER2-Expressing Oncolytic Herpes Simplex Virus Induces Robust and Persistent Immune Response against HER2-Positive Tumor Cells
Zahid M. Delwar, Olga Tatsiy, Dmitry V. Chouljenko, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1805-1805
Open Access
Page 1

Scroll to top